Genetic and molecular epidemiology of adult diffuse glioma
By Annette M. Molinaro, Jennie W. Taylor, John K. Wiencke, M. Wrensch. Nature Reviews Neurology, 2019
609 citations recorded by the source corpus.
The WHO 2007 glioma classification system (based primarily on tumour histology) resulted in considerable interobserver variability and substantial variation in patient survival within grades. Furthermore, few risk factors for glioma were known. Discoveries over the past decade have deepened our understanding of the molecular alterations underlying glioma and have led to the identification of numerous genetic risk factors. The advances in molecular characterization of glioma have reframed our understanding of its biology and led to the development of a new classification system for glioma. The WHO 2016 classification system comprises five glioma subtypes, categorized by both tumour morphology and molecular genetic information, which led to reduced misclassification and improved consistency of outcomes within glioma subtypes. To date, 25 risk loci for glioma have been identified and several rare inherited mutations that might cause glioma in some families have been discovered. This Review focuses on the two dominant trends in glioma science: the characterization of diagnostic and prognostic tumour markers and the identification of genetic and other risk factors. An overview of the many challenges still facing glioma researchers is also included.In this Review of adult diffuse gliomas, Molinaro et al. discuss the latest epidemiological data and highlight advances from the past decade, including the identification of genetic and other risk factors for glioma included in the 2016 WHO integrated classification system.Key pointsGlioma incidence differs by age, sex, ethnicity and geography whereas glioma survival varies by tumour subtype, age and sex.In the past decade, multiple discoveries have expanded our understanding of glioma and led to a new classification system (WHO 2016) that integrates molecular alterations and histology.The WHO 2016 classification system defines five glioma subtypes that have improved homogeneity in their clinical outcomes.Twenty-five risk loci for glioma and several rare inherited mutations that might cause glioma in some families have been identified; however, ionizing radiation is the only confirmed environmental risk factor.
Subfields: Cancer Research, Genetics
View Paper: https://www.semanticscholar.org/paper/5b21bf78a887e4afcd7306c95944fbabd81bbef8
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
Citations in the corpus
- Targeting TGF-β signal transduction for fibrosis and cancer therapy (2022, background): “Diffusely infiltrating gliomas are more malignant than circumscribed gliomas, in which glioblastoma is the most lethal glioma, with a median overall survival of 14–17 months [210, 211].”